Login to Your Account



AGI Grosses EUR 42.5M In Dublin, London IPO

By Cormac Sheridan


Wednesday, March 1, 2006
DUBLIN, Ireland - AGI Therapeutics plc, a specialty pharma company established by former Elan Corp. plc executives, raised gross proceeds of €42.5 million ($50.3 million) in an initial public offering Monday on the Irish Stock Exchange in Dublin and the Alternative Investment Market in London. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription